India is making strides in cancer treatment through advanced genetic research. A recent project aims to identify genetic mutations in cancer patients to tailor treatments better. This approach could help doctors avoid ineffective chemotherapy and minimize side effects. Remarkably, about 57% of Indian cancer patients have mutations that doctors are actively working to understand for better treatment options.
Currently, the cost of whole genome sequencing for a single patient ranges from Rs 60,000 to Rs 1 lakh. However, experts believe prices will decrease as technology improves and specific Indian mutations are identified. The project has already gathered samples from nearly 8,000 patients, with plans for significant expansion.
IIT Madras Director V Kamakoti highlighted an important point: many Indian patients have unique genetic variations not found in Western populations. This could help explain the higher mortality rates in certain cancers, including breast cancer. Treatments designed for Western patients might not be as effective for Indians, making this research crucial.
Dr. SG Ramanan, a senior oncologist at Apollo Hospitals, emphasized the need for medical professionals to be trained in interpreting complex genetic data. He believes that education is vital, and creating molecular tumor boards will be key to translating this data into clinical practices.
The project also received significant support from Hyundai Motor India, contributing Rs 56 crore under their Hyundai Hope for Cancer initiative. Additionally, Rs 3 crore has been set aside to help provide treatment for children from economically disadvantaged backgrounds.
This initiative represents a significant movement towards personalized and affordable cancer care in India. With ongoing research and collaboration, the future of cancer treatment can be brighter for patients across the nation.
For more information on genetic mutations in cancer, check out this study from the National Cancer Institute that details advancements in personalized medicine.
Source link
IIT Madras,cancer genome database,Indian patients
